Cargando…

Serum Soluble CD14 Is a Potential Prognostic Indicator of Recurrence of Human Breast Invasive Ductal Carcinoma with Her2-Enriched Subtype

In clinical practice, breast cancers with lymph node positive, ER/PR-negative and overexpressed human epidermal growth factor receptor 2 (LN+ER/PR-Her2+) have high risk of recurrence, but the effective biomarkers of prognostic for this type tumor are still lacking. Since breast cancers with LN+ER/PR...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Weifeng, Tong, Yifan, Wang, Ying, Liu, Jingjing, Luo, Gaoxing, Wu, Jun, Zhang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783397/ https://www.ncbi.nlm.nih.gov/pubmed/24086515 http://dx.doi.org/10.1371/journal.pone.0075366

Ejemplares similares

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)

Evaluation of a soluble CD14 subtype in patients with surgical sepsis
por: Fukui, Y
Publicado: (2012)

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2
por: Solek, Julia, et al.
Publicado: (2022)

Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis
por: Sato, Masayuki, et al.
Publicado: (2015)

Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates
por: Pugni, Lorenza, et al.
Publicado: (2015)

Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study
por: Foca, A, et al.
Publicado: (2014)

Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients
por: Klouche, Kada, et al.
Publicado: (2016)

Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis
por: van Maldeghem, Iris, et al.
Publicado: (2019)

Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers
por: LeVan, Tricia D., et al.
Publicado: (2017)

CD14+ monocytes and soluble CD14 of synovial fluid are associated with osteoarthritis progression
por: Lee, Ha-Reum, et al.
Publicado: (2022)

Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021)

Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial
por: Pietrasanta, Carlo, et al.
Publicado: (2021)

Alu and LINE-1 Hypomethylation Is Associated with HER2 Enriched Subtype of Breast Cancer
por: Park, So Yeon, et al.
Publicado: (2014)

TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis?
por: Konstantinidou, Maria Kalliopi, et al.
Publicado: (2016)

Soluble CD14 participates in the response of cells to lipopolysaccharide
Publicado: (1992)

Presepsin (soluble CD14 subtype) as a risk factor for the development of infectious and inflammatory complications in operated colorectal cancer patients
por: Shakeyev, Kayrat, et al.
Publicado: (2022)

The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis
por: Pateisky, Petra, et al.
Publicado: (2016)

Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma
por: Chung, Hye Won, et al.
Publicado: (2014)

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial
por: Masson, Serge, et al.
Publicado: (2014)

Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model
por: Nakamura, M, et al.
Publicado: (2008)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma
por: Zhao, Juan, et al.
Publicado: (2022)

Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment
por: Behnes, Michael, et al.
Publicado: (2014)

Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection
por: Uysal, Hayriye Kırkoyun, et al.
Publicado: (2016)

HER2 overexpression in ductal carcinoma in situ is associated with ipsilateral breast cancer recurrence after conservative surgery
por: Gong, Di-He, et al.
Publicado: (2020)

Increased Soluble CD155 in the Serum of Cancer Patients
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2016)

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
por: Bergamino, Milana A., et al.
Publicado: (2022)

CD8(+) tumor‐infiltrating lymphocytes contribute to spontaneous “healing” in HER2‐positive ductal carcinoma in situ
por: Morita, Michi, et al.
Publicado: (2016)

Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients
por: Ha, June-Hyung, et al.
Publicado: (2014)

Chemotherapy of HER2- and MDM2-Enriched Breast Cancer Subtypes Induces Homologous Recombination DNA Repair and Chemoresistance
por: Herok, Marcin, et al.
Publicado: (2021)

Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis
por: Ogawa, Yuji, et al.
Publicado: (2013)

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment
por: Shen, Guoshuang, et al.
Publicado: (2021)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Enhancement of soluble CD28 levels in the serum of Graves’ disease
por: Sun, Zhongwen, et al.
Publicado: (2014)

Soluble CD93 in Serum as a Marker of Allergic Inflammation
por: Park, Hye Jung, et al.
Publicado: (2017)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2
por: Mostafa, Gehan Ahmed, et al.
Publicado: (2022)

LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand
por: Damien, Pauline, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rsdlpmr17544usaqhhqpd9tdfd